Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VOELCKER G")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1

Export

Selection :

  • and

FLUOROMETRISCHE BESTIMMUNG VON "AKTIVIERTEM" CYCLOPHOSPHAMID UND IFOSFAMID IM BLUT = DOSAGE FLUORIMETRIQUE DU CYCLOPHOSPHAMIDE ET DE L'IFOSFAMIDE ACTIVES DANS LE SANGVOELCKER G; HAEGLSPERGER R; HOHORST HJ et al.1979; J. CANCER RES. CLIN. ONCOL.; DEU; DA. 1979; VOL. 93; NO 3; PP. 233-240; ABS. ENG; BIBL. 13 REF.Article

ZUR BINDUNG VON CYCLOPHOSPHAMID UND CYCLOPHOSPHAMID-METABOLITEN AN SERUM-ALBUMIN. = LA FRACTION DU CYCLOPHOSPHAMIDE ET DES METABOLITES DU CYCLOPHOSPHAMIDE A L'ALBUMINE DU SERUMVOELCKER G; GIERA HP; JAGER L et al.1978; Z. KREBSFORSCH. KLIN. ONKOL.; DTSCH.; DA. 1978; VOL. 91; NO 2; PP. 127-142; ABS. ANGL.; BIBL. 1 P. 1/2Article

UEBER BLUTSPIEGEL UND URIN-AUSSCHEIDUNG VON AKTWIERTEN CYCLOPHOSPHAMID UND SEINEN DEAKTIVIERUNGSPRODUKTEN BEIM MENSCHEN = CONCENTRATION SANGUINE ET EXCRETION URINAIRE DU CYCLOPHOSPHAMIDE ET DE SES METABOLITES INACTIFS CHEZ L'HOMMEWAGNER T; HEYDRICH D; VOELCKER G et al.1980; J. CANCER RES. CLIN. ONCOL.; DEU; DA. 1980; VOL. 96; NO 1; PP. 79-92; ABS. ENG; BIBL. 2 P.Article

Structure/activity studies with thiazolidinyl- and perhydrothiazinylphosphamide esterVOELCKER, G; HOHORST, H.-J.Journal of cancer research and clinical oncology. 1998, Vol 124, Num 6, pp 297-300, issn 0171-5216Article

Kostensenkung beim Schleifen von Schraubendruckfedern durch Differenzierung der Schleifscheibenqualitaeten = Cost reduction at grinding of helical springs by grinding wheel qualityDORN, W; VOELCKER, G.Draht. 1983, Vol 34, Num 11, pp 552-553, issn 0012-5911Article

COMPARATIVE STUDY ON HUMAN PHARMACOKINETICS OF ACTIVATED IFOSFAMIDE AND CYCLOPHOSPHAMIDE BY A MODIFIED FLUOROMETRIC TESTWAGNER T; HEYDRICH D; JORK T et al.1981; Z. KREBSFORSCH. KLIN. ONKOL.; ISSN 0084-5353; DEU; DA. 1981; VOL. 100; NO 1; PP. 95-104; BIBL. 35 REF.Article

CHARACTERIZATION AND QUANTITATIVE ESTIMATION OF ACTIVATED CYCLOPHOSPHAMIDE IN BLOOD AND URINE.WAGNER T; PETER G; VOELCKER G et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 8 PART. 1; PP. 2592-2596; BIBL. 24 REF.Article

MASS SPECTROMETRIC CHARACTERIZATION OF ACTIVATED N-(2-CHLOROETHYL) AMIDO OXAZAPHOSPHORINE DERIVATIVES.PRZYBYLSKI M; RINGSDORF H; LENSSEN U et al.1977; BIOMED. MASS SPECTROM.; G.B.; DA. 1977; VOL. 4; NO 4; PP. 209-215; BIBL. 29 REF.Article

ZUM PROBLEM DER IN VITRO. SENSIBILITAETSTESTUNG VON TUMORENGEGEN CYCLOPHOSPHAMID, 3H-URIDINE INBAU IN RIBONUCLEINSAEURE MENSCHLICHER TUMORZELLEN NACH INKUBATION MIT 4-HYDRO-PEROXY-CYCLOPHOSPHAMID. II = ETUDE IN VITRO DE LA SENSIBILITE DES TUMEURS HUMAINES AU CYCLOPHOSPHAMIDE: EFFET DE L'HYDROPEROXY-4 CYCLOPHOSPHAMIDE SUR L'INCORPORATION DE L'URIDINE-3H DANS LES ACIDES RIBONUCLEIQUES DE CELLULES TUUMORALES HUMAINESBASTERT G; VOELCKER G; PETER G et al.1976; KREBSFORSCH. KLIN. ONKOL.; DTSCH.; DA. 1976; VOL. 85; NO 3; PP. 299-307; ABS. ANGL.; BIBL. 24 REF.Article

IN-VITRO TESTING OF CYCLOPHOSPHAMIDE ON TUMORS.KAUFMANN M; MATTERN J; VOLM M et al.1975; NATURWISSENSCHAFTEN; DTSCH.; DA. 1975; VOL. 62; NO 4; PP. 446-447; BIBL. 8 REF.Article

Activated cyclophosphamide: an enzyme-mechanism-based suicide inactivator of DNA polymerase/3'-5'-exonucleaseBIELICKI, L; VOELCKER, G; HOHORST, H. J et al.Journal of cancer research and clinical oncology. 1984, Vol 107, Num 3, pp 195-198, issn 0171-5216Article

Thiazolidinyl- and perhydrothiazinylphosphamidesters : toxicity and preliminary antitumour evaluationVOELCKER, G; BIELICKI, L; HOHORST, H.-J et al.Journal of cancer research and clinical oncology. 1997, Vol 123, Num 11-12, pp 623-631, issn 0171-5216Article

Synthesis and characterization of 2-mercaptoethanesulfonic acid albuminBAUER, H.-H; EHMIG, S; ENGELS, J. W et al.Arzneimittel-Forschung. 1998, Vol 48, Num 6, pp 691-693, issn 0004-4172Article

Intrakavitäre Chemotherapie des S 180-Ascites-Sarkoms der Maus mit 4-(S-Ethanol)-sulfido-cyclophosphamid in Kombination mit Protektorthiolen = Chimiothérapie intracavitaire à dose forte du sarcome 180 chez la souris avec 4-S-(éthanol)-sulfidocyclophosphamide associé à des thiols-protecteurs = Intracavitary high volume i. p. chemotherapy of the ascites sarcoma 180 in mice with 4-(S-ethanol)-sulfido-cyclophosphamide in combination with protector thiolsVOELCKER, G; JASCHKE, A; WRABETZ, E et al.Arzneimittel-Forschung. 1984, Vol 34, Num 10, pp 1291-1298, issn 0004-4172Article

Increased antitumour activity of mesyl-I-aldophosphamide-perhydrothiazine, in vivo but not in vitro, compared to I-aldophosphamide-perhydrothiazineVOELCKER, G; PFEIFFER, B; SCHNEE, A et al.Journal of cancer research and clinical oncology. 2000, Vol 126, Num 2, pp 74-78, issn 0171-5216Article

Low toxicity cancer chemotherapy by suicide inactivation of DNA polymerase α holoenzyme: first results with new thiazolidinyl- and perhydrothiazinyl-ethyl-N-mustard-phosphamide estersHOHORST, H.-J; BIELICKI, L; MÜLLER, K et al.Journal of cancer research and clinical oncology. 1988, Vol 114, Num 3, pp 309-311, issn 0171-5216Article

The embryotoxicity of cyclophosphamide in rabbits during the histiotrophic phase of nutritionCLAUSSEN, U; HETTWER, H; VOELCKER, G et al.Teratogenesis, carcinogenesis, and mutagenesis. 1985, Vol 5, Num 2, pp 89-100, issn 0270-3211Article

  • Page / 1